Abatacept - Bristol-Myers Squibb
At a glance
- Drug Originator Bristol-Myers Squibb
- Drug Licenced by Ono Pharmaceutical; Simcere Pharmaceutical Group
- Drug Class Anti-inflammatories; Antipsoriatics; Antirheumatics; Eye disorder therapies; Immunoglobulin fragments; Immunoglobulin fusion proteins; Recombinant fusion proteins; Skin disorder therapies; Urologics
- Mechanism of Action T cell activation inhibitors
- USA Patent Applicants BRISTOL MYERS SQUIBB
- USA Patents 118
- BLAs 1
- International Patents 1,842
Disclaimer